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ABSTRACT
Oral Cancer in Nevada: A Public Health Perspective
by
Karl Kingsley, PhD
Michelle Chino, Thesis Committee Chair
Associate Professor, School of Community Health Sciences
University of Nevada, Las Vegas

Cancer is the second leading cause of death in the United States, and oral
cancer remains the eighth leading cause of cancer death among US males. Although
previous epidemiologic studies have found that overall rates of cancer, including oral
cancer, have declined in the US in recent decades – these declines are neither uniform
nor consistent within this population. Anecdotal evidence has suggested that rates of
oral cancer in Nevada are relatively high, although no evidence was available to
support these assertions.
Oral Cancer Epidemiology: Based upon this information, a detailed and
thorough epidemiologic examination of oral cancer rates in Nevada was undertaken.
Chapter 1 describes a landmark publication in the journal BMC Public Health, which
clearly demonstrated that oral cancer rates are, in fact, rising in specific geographic
areas. Moreover, the state with the highest documented sustained increases was
Nevada. In addition, although previous research has demonstrated increasing oral
cancer rates among women and minorities, due to increased wealth, status and access
over these past few decades – the observed increases in Nevada’s oral cancer rates
were overwhelmingly within the white male population.
Risk Factor Analysis: In a follow-up study to determine the factors responsible
for the rising rates of oral cancer in Nevada, an in-depth analysis of the primary risk
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factor for oral cancer development (tobacco usage) was performed.

Chapter 2

outlines this study, submitted for publication in the journal Tobacco-Induced
Diseases. These results demonstrated that the increased incidence and mortality of
oral cancer in Nevada was a state-specific phenomenon and not part of a larger,
regional increase.

Moreover, trend analysis revealed that tobacco usage rates,

although historically higher and linked to other factors, such as lower pricing, taxes
and fewer workplace smoking bans, were recently found to be declining. These
findings are the first to provide evidence that suggests that rates of oral cancer within
this specific geographic area may soon begin to decline.
Environmental Factors: In addition to tobacco usage (smoking), many other
risk factors may play a role in the development of oral cancers. These additional risk
factors include environmental factors, such as nutrition and diet, which are examined
in Chapter 3. For example, the recent adoption for required folate fortification in
some food products, which has been shown to reduce negative health outcomes
related to folate deficiency, has also been demonstrated to increase the rate of growth
in undiagnosed (but pre-existing) colorectal cancers. This raises the question of
whether folate may play a similar and significant role in the accelerated growth of
other slow developing cancers, such as oral cancers. The timing of folate fortification
in the US parallels the increased incidence of oral cancer in Nevada, suggesting that
this environmental influence may also play an important role in the development and
progression of this disease.
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CHAPTER 1
ANALYSIS OF ORAL CANCER EPIDEMIOLOGY IN THE US REVEALS
STATE-SPECIFIC TRENDS: IMPLICATIONS FOR ORAL CANCER
PREVENTION
This chapter has been published in the peer-reviewed scientific journal BMC Public
Health and is presented in the style of that journal. The complete citation is:
Kingsley K, O’Malley S, Chino M. Analysis of oral cancer epidemiology in the US
reveals state-specific trends: implications for oral cancer prevention. BMC Public
Health 2008 8(1): 87.
Abstract
Background: Downward trends have been observed in oral cancer incidence
and mortality in the US over the past 30 years; however, these declines are not
uniform within this population. Several studies have now demonstrated an increase in
the incidence and mortality from oral cancers among certain demographic groups,
which may have resulted from increased risks or risk behaviors. This study examines
the underlying data that comprise these trends, to identify specific populations that
may be at greater risk for morbidity and mortality from oral cancers.
Methods: Oral cancer incidence and mortality data analyzed for this study
were generated using the National Cancer Institute’s Surveillance, Epidemiology and
End Results (SEER) program.
Results: While oral cancer incidence and mortality rates have been declining
over the past thirty years, these declines have reversed in the past five years among
some demographic groups, including black females and white males. Sorting of these
data by state revealed that eight states exhibited increasing rates of oral cancer deaths,
Nevada, North Carolina, Iowa, Ohio, Maine, Idaho, North Dakota, and Wyoming, in
stark contrast to the national downward trend. Furthermore, a detailed analysis of
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data from these states revealed increasing rates of oral cancer among older white
males, also contrary to the overall trends observed at the national level.
Conclusions: These results signify that, despite the declining long-term trends
in oral cancer incidence and mortality nationally, localized geographic areas exist
where the incidence and mortality from oral cancers have been increasing. These
areas represent sites where public health education and prevention efforts may be
focused to target these specific populations in an effort to improve health outcomes
and reduce disparities within these populations.
Roles of authors:
Karl Kingsley, PhD
MPH candidate
Primary author
Data generation
Study design
Susan O’Malley, MEd, MS
Research Associate
Secondary author
Data analysis and manuscript editing
Marcia Ditmyer, PhD
Assistant Professor
Secondary author
Interpretation of data
Michelle Chino, PhD
Associate Professor
Research Mentor
MPH Committee Chair
Background
Although rates of oral cancer incidence and mortality in the US have declined
over the past few decades, these declines have not been consistent or uniform within
this population [1-4]. Collaborative reports using data from the National Cancer
Institute (NCI), the Centers for Disease Control and Prevention (CDC) and the
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American Cancer Society (ACS) have found increases in the incidence of oral cancer
among specific segments of the population, including minorities [5-7]. While many
advances in treatment and diagnosis have been made over the past three decades, oral
cancer remains the eighth leading cause of cancer death among US males [8] and the
five-year survival rate has remained low and relatively unchanged [9, 10]. Cancer
remains the second leading cause of death in the US [11], and these observed
increases in oral cancer provide compelling rationale for this study examining data
underlying the general declining trends to elucidate which specific subsets of the
population, as well as specific states or regions, that face increasing oral cancer rates.
Recently, studies of oral cancer epidemiology demonstrated statistically
significant differences in oral cancer rates among population subgroups, including
minorities and various age groups, and between genders [12].

One such study

demonstrated that although incidence rates of oral cancer have been steadily
decreasing among white males, incidence rates among older black males (>65 years
old) have been increasing [13]. In addition, this study demonstrated that oral cancer
rates among females, in particular, have increased [13]. Although these data provide
some evidence of the disparities in oral cancer rates between these populations, a
more detailed examination may identify states, metropolitan areas or communities, as
well as additional population sub-groups within these areas, which are experiencing
increases in oral cancer incidence or mortality.
This study will examine the underlying data that comprise the general trends,
to identify specific populations within the US that may be at greater risk for morbidity
and mortality from oral cancers. Epidemiology studies of oral cancer in Europe have
found incidence and mortality rates have been declining steadily over the past few
decades, similar to the trends found in the US, although more detailed analyses of the
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underlying data revealed that persistent upward trends were still present in a small
subset of eastern European countries [14-18]. To perform a similar analysis for
specific US states and counties, the NCI Surveillance, Epidemiology and End Results
(SEER) website [19], a collaborative effort between the NCI and CDC, in conjunction
with all US state registries, provides an interface for epidemiologists and other
researchers to access and generate oral cancer statistics [20]. Due to the recently
observed increases in oral cancer among particular segments of the US population, a
more detailed analysis of the underlying data which comprise these general, long-term
declining trends provides valuable information about significant short-term increases
in specific geographic areas and among specific demographic groups.
Methods
Data sources: Population-based data for the US, specific to oral cancer, were
obtained from the Surveillance, Epidemiology, and End Results (SEER) program.
SEER provides cancer incidence and survival data from population-based cancer
registries, representing approximately 25% of the US population [21].

All oral

cancer statistics in this report are based on SEER incidence and National Center for
Health Statistics (NCHS) mortality statistics, which consisted of cancers of the oral
cavity and pharynx, including the lip, oral cavity and pharynx [22].
Incidence: Oral cancer incidence rates for each year between 1975 and 2004
were obtained from SEER, age-adjusted to the year 2000 standard US population.
The overall incidence trends for each time period (1975-2004; 1995-2004; 20002004) were then calculated and subsequently graphed based on these data, dividing
the most recent incidence rate by each specific earlier rate.
Mortality: Oral cancer mortality rates for each year between 1975 and 2004,
age-adjusted to the year 2000 standard US population, were also obtained from SEER.
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Data qualified for inclusion in SEER as oral cavity and pharyngeal cancer if the
underlying cause of death was specific for oral cancers [20]. The overall mortality
trends over time for each time period (1975-2004; 1995-2004; 2000-2004) were
calculated and graphed based on data from 1975-2004, dividing the most recent
mortality rate by earlier rates.
Annual percent change (APC) 1999-2003:Recent trend data in death rates
from oral cancer from individual US states were calculated from the State Cancer
Registries in SEER using the Joinpoint Regression Progression and are expressed as
the APC over the reported trend period (1999-2003). Current annual death rates of
oral cancers from individual US states were similarly obtained and the most recent
data available (2003, 2004) at the time of article preparation were reported. Data
were exported to Microsoft Excel, sorted in ascending order and graphed.
US state data: Historical mortality data for cancers of the oral cavity and
pharynx from selected US states, including Nevada, Idaho, North Dakota, and North
Carolina, were calculated by NCI SEER*Stat, from data provided by the National
Vital Statistics System public use data file. Trends are based upon analysis calculated
using the Joinpoint Regression Program statistical software program, which models
the natural logarithm of the rates, identifying years at which any given trend changes,
connecting these years graphically by a series of straight line segments [23, 24].
Results
Age-adjusted incidence and mortality rates: Age-Adjusted Incidence Rates
(AAIR) and Age-Adjusted Mortality Rates (AAMR) were generated and sorted by
race and gender to gather more detailed information regarding oral cancer trends (Fig.
1). The oral cancer incidence and mortality trends were then further delineated into
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three, distinct time periods, 1975-2004 (30 year), 1995-2004 (10 year) and 2000-2004
(5 year), to allow for greater specificity within the overall temporal trend analysis.
Age-adjusted incidence rates (AAIR): Analysis of the AAIR data revealed an
overall declining trend in oral cancer incidence over the past 30 years (Fig. 1A).
More specifically, over the past 30 years, oral cancer incidence has declined among
white males (-1.21%), white females (-0.66%), black males (-1.53%) and black
females (-1.38%), although these observed declines have not been uniform across
time or demographic groups. For example, although the incidence of oral cancer
among black males has declined over the past 30 years, the temporal stratification of
these data revealed that this decline was greatest over the past five years (-6.64%).
Furthermore, this stratification also revealed a contrasting trend; the incidence of oral
cancer among black females rose from -1.38%, over the entire 30 year period, to
+3.18% during the most recent five year period.
Age-adjusted mortality rates (AAMR): Analysis of the AAMR data also
revealed an overall declining trend in oral cancer mortality over the past 30 years
(Fig. 1B).

Although overall mortality decreased over 30 years for all groups

analyzed, white males (-2.16%), white females (-1.62%), black males (-1.92%) and
black females (-1.71%), more specific temporal analysis of oral cancer mortality
revealed at least two distinct trends. First, the decreases in mortality were greatest
over the last 10 year period compared to the last 30 years and much less pronounced
over the more recent five year period. This trend was observed for white females,
black males, and black females, but not white males. The second trend, found only
among white males, revealed that mortality, although still declining, was declining by
ever smaller amounts over each time period: 30 years (-2.16%), 10 years (-1.83%),
and five years (-0.33%).
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Geographic distribution: To determine if the temporal shifts observed in oral
cancer incidence and mortality were associated with specific geographic regions or
states, AAIR and AAMR were generated for all US states (Fig. 2). AAIR and AAMR
data were then further delineated into quantile intervals to highlight the rates for each
state relative to the US averages, from highest (red) to lowest (dark blue).
AAIR geographic distribution: Analysis of the AAIR geographic distribution
data identified seven states in the highest quantile (11.7 to 13.7 cases per 100,000),
the District of Columbia (13.7), Oklahoma (12.7), Louisiana (12.7), Georgia (12.6),
Florida (12.5), Maine (12.2) and New Hampshire (11.8) (Fig. 2A). Seven additional
states were identified within the second highest quantile (11.0 to 11.6), Maryland
(11.6), Alabama (11.5), Wisconsin (11.5), Missouri (11.4), Kentucky (11.4), Nevada
(11.2) and Massachusetts (11.0). All states within the two highest quantiles were
located in the Eastern and Central zones, with the exception of Nevada (Pacific).
AAMR geographic distribution: Analysis of the AAMR geographic
distribution data revealed seven states within the highest quantile (3.3 to 4.4 deaths
per 100,000), the District of Columbia (4.4), Arkansas (3.5), South Carolina (3.5),
Louisiana (3.4), Alabama (3.3), Maine (3.3) and Nevada (3.3) (Fig. 2B). The second
highest quantile was comprised of four states, New Hampshire (3.2), Wyoming (3.2),
Mississippi (3.0) and Tennessee (3.0). Once again, the majority of states within the
two highest quantiles were located in the Eastern and Central zones of the US, with
the exception of Nevada (Pacific) and Wyoming (Mountain).
Annual percent change in US states: The graphic organization of specific
states with the highest levels of oral cancer incidence and mortality provides
significant information regarding the geographic regions which are associated with
these highest levels. This information does not, however, delineate the areas which
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have high levels of oral cancer incidence and mortality that are slowly decreasing
over time and those that are increasing. To make this determination, the most recent
five year interval was selected to provide a more detailed temporal and geographic
breakdown of the states reporting oral cancer incidence or mortality within the two
highest quantiles, to determine if the annual percent change (APC) was decreasing at
a slower rate, or increasing over time (Table 1).
APC in US states with elevated incidence: Analysis of APC from the stratified
AAIR data identified 14 states that were in the highest quantiles for oral cancer
incidence (Table 1). Of these states, 12 were found to have negative APC, which
indicates a continuing decreasing trend in oral cancer incidence over the most recent
five-year interval, although most of these decreases were comparatively lower than
observed over the longest time interval (30 years). Two states which did not follow
this trend, however, and that were found to have increasing APC, were Maine
(+2.2%) and Nevada (+4.6%).
APC in US states with elevated mortality: Analysis of APC from the stratified
AAMR data identified 11 states that were in the highest quantiles for oral cancer
mortality (Table 1). Of these states, eight were found to have negative APC, which
suggests a continuing decreasing trend in oral cancer mortality, although most of the
decreases were also comparatively lower than observed over the longest time interval
(30 years).

Three states, however, were found to have increasing APC, Maine

(+2.2%), Nevada (+4.6%) and Wyoming (+0.1%).
US states with positive APC: Although we identified states with positive APC,
in the highest quantiles for both oral cancer incidence and mortality (Maine, Nevada),
one additional state was found to have positive APC, which was only found among
the states with elevated mortality. To determine if other states had increasing APC,
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but were not among the states with the highest overall levels of oral cancer incidence
or mortality, we expanded this analysis to include data for all US states. This analysis
revealed that eight states had increasing APC in oral cancer mortality (Fig. 3). These
states were Nevada (+4.6%), North Carolina (+4.0%), Iowa (+3.5%), Ohio (+3.4%),
Maine (+2.2%), Idaho (+1.0%), North Dakota (+0.5%) and Wyoming (+0.15), only
three of which were among the states with either the highest oral cancer incidence or
mortality.
Having identified eight states with recent increasing or positive trends (APC),
a more detailed analysis of each of these states was performed to further examine
these trends within each state. The more detailed analysis of each state, year-to-year,
spanning a 25 year period revealed significant, increasing trends in only four of these
states, Nevada (Fig. 4), Idaho (Fig. 5), North Dakota (Fig. 6) and North Carolina (Fig.
7).
Nevada: Oral cancer mortality data for Nevada, the state with the highest fiveyear APC (+4.6%), were stratified by race and gender (Fig. 4). The analysis revealed
that although the rates of oral cancer were decreasing for many years (1980-1997), a
distinct upward trend was noted (1998-2004). Moreover, this trend was most closely
associated with white males (Fig. 4A). The data for white males were then further
stratified by age, revealing that the recent upward trends in oral cancer mortality were
almost exclusively associated with white males over 50, and especially with white
males over 65 (Fig. 4B).
Idaho: Oral cancer mortality data for Idaho, another state identified with a
positive five-year APC (+1.0), were also sorted by both race and gender (Fig. 5). The
results from this stratification revealed that the rates of oral cancer in Idaho have been
slowly increasing for many years (1980-2004). More specifically, this trend was
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associated almost exclusively with white males (Fig. 5A), with too few data points to
support trend analysis for any other race or gender grouping. Separating the data for
white males by age revealed that this upward trend was associated with white males
over 50, but not older than 65 (Fig. 5B).
North Dakota: Oral cancer mortality data for North Dakota, a state with a
small, positive five-year APC (+0.5%), were also sorted by race and gender (Fig. 6).
The results from this analysis revealed that rates of oral cancer in North Dakota have
been slowly increasing over many years (1980-2004) and the increases were also
associated with white males (Fig. 6A). After separating these data by age, the results
did not find this trend was associated with any specific age group (Fig. 6B).
North Carolina: Oral cancer mortality data for North Carolina, a state with a
positive five-year APC (+4.5%), were also sorted by race and gender (Fig. 7). The
results from this analysis, however, revealed that the recent increasing trend in oral
cancer mortality (2001-2004) was primarily associated with black males (Fig. 7A).
After the data for black males were further stratified by age, the upward trend was
most closely associated with black males over 50, but not older than 65 (Fig. 7B).
Discussion
Although cancer ranks as the second leading cause of death in the United
States, after heart disease, and remains an important problem facing public health
professionals, the overall rates of cancer deaths have been steadily declining over the
past few decades [25].

While this declining trend is welcome news for the general

population and health professionals, it does not accurately describe the details which
underlie these trends in which rates for some types of cancer have decreased
significantly, while rates of other cancers have displayed opposing, increasing trends
[11]. For example, although rates of lung cancer have steadily declined for decades,
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cancers of the liver and thyroid have increased over the same period [3, 11, 26]. In
the same fashion, the overall declining rates observed for oral cancer may obfuscate
the underlying data which suggest that while the rates are declining among whites,
they may be simultaneously increasing among other ethnic or demographic groups,
such as blacks and females [13, 27].
To accurately understand the changes in oral cancer incidence and mortality, it
is important to examine not only the composite data which describe the general trends
for the US population over many years, but also to scrutinize the primary core data
which convey more detailed information. For example, these core data may include
shorter intervals and year-by-year trends, as well as demographic and geographic
breakdowns. Although previous reports have noted that oral cancer incidence and
mortality rates are not uniform across demographic groups [13, 27], this report is
among the first to describe that oral cancer rates may be increasing over the short
term, and that these increases are restricted to a small subset of states and particular
demographic groups.
Previous studies have described an overall declining trend in oral cancer
incidence and mortality with the understanding that these decreases were found
primarily among whites, and were not offset by smaller increases among other
demographic groups [20, 28].

This report, however, provides evidence of three

distinct trends, not previously articulated. First, although oral cancer incidence and
mortality have declined over the past thirty years, with the most significant declines
observed over the past ten years, a reversal of these trends has emerged from the
short-term (over the past five years) trend analysis, which may signify an important
development in the epidemiology of this cancer.

Next, this report provides a

geographic profile of oral cancer rates over time, revealing that although oral cancer
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rates are continuing to decline in most states, they are now in fact increasing in a
small subset of states. Finally, in-depth stratification of data from these specific states
revealed that oral cancer rates are increasing almost exclusively among older white
males in three of these states, in sharp contrast to the general national trends.
The identification of differential oral cancer trends among specific geographic
areas and demographic groups in the US could indicate a shift in the epidemiology of
this cancer. A recent large-scale study among European countries revealed similar
temporal and geographic trends [18]. For example, although oral cancer incidence
and mortality has steadily declined in Europe as a whole since the 1980s, more
detailed analysis by geographic region (country) revealed that mortality was rising in
a subset of eastern European countries, most notably in Bulgaria, Romania, Hungary,
Slovakia and Slovenia [16, 17]. Based upon these observations, the study authors
speculated that the temporal and geographic nature of these patterns was related to
changes in exposure to the two major risk factors for oral cancer, alcohol and tobacco.
These items became more readily available and widely disseminated in these areas
following the disintegration and break-up of the Soviet Union [18].
Perhaps the increasing oral cancer trends identified in this study, in specific
states and among specific demographic groups, are related to identifiable trends in
oral cancer risk factors and behaviors, such as increased tobacco use or alcohol
consumption, as was found in eastern European countries.

The most recent

Behavioral Risk Factor Surveillance System (BRFSS) data confirms that six of the
eight states identified in this report with increasing trends in oral cancer mortality
were also among the states with higher than average rates of current smokers, which
include Ohio, Nevada, North Carolina, Wyoming, Iowa and Maine [29]. Moreover,
these states were also among the states with higher than average rates of heavy
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alcohol consumers, with the exception of North Carolina.

Although these data

suggest a correlation between alcohol and tobacco consumption patterns and oral
cancer in these areas and among these demographic groups, the BRFSS data also
provide some conflicting evidence, revealing that the states with the highest levels of
current smokers and heavy alcohol consumers (Kentucky and Wisconsin,
respectively) were not among those states with increasing rates of oral cancer
incidence and mortality, but rather have decreasing rates, indicating that other risk
factors may also be significant contributing factors.
Although tobacco and alcohol consumption are the main risk factors for
developing oral cancer, implicated in as many as 90 to 95% of head and neck cancers,
other potential risk factors have recently emerged [30]. For instance, evidence for the
role of infectious agents in the etiology of oral cancers has been mounting,
demonstrating that oral infection with high-risk human papillomavirus (HPV) may not
only increase the risk of developing oral cancer, but may also contribute to its
progression [31, 32].

Other infectious agents and immune modulators, such as

infection with the human immunodeficiency virus (HIV) and immune suppression,
induced mainly via pharmacologic means to prevent rejection of transplanted organs,
also significantly increase the risk of developing oral cancer [12]. In addition, recent
evidence demonstrates that nutrition may play an important role in retarding the
development and progression of oral cancers, revealing a nearly 50% reduction in oral
cancer risk for each additional portion of fruits or vegetables consumed per day, even
among tobacco and alcohol consumers [33-36].

Identifying those demographic

groups and geographic areas experiencing increases in oral cancer will help direct
public health research to understand how and why these rates may be increasing.
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Conclusions
It is imperative that further analysis of the contributing factors that underlie
these temporal and geographic trends be undertaken.

This information may be

indispensable to public health professionals as they strive to design populationspecific prevention and education programs, which are often funded and implemented
at the local, regional and state levels. Because many of the lifestyle behaviors which
contribute to oral cancer risk are possible to impact through public health education
and prevention strategies, more effective targeting of public health monies and efforts,
towards the specific geographic regions and demographic populations which face
these increased risks, may help to reverse these disturbing trends of increasing oral
cancer, as outlined in this study.
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Figure 1 - Incidence and mortality trends for oral cancer in the US: Trends for the
incidence (A) and mortality (B) rates of oral cancer cases reported to the SEER
program from 1975-2004 in the US were sorted by time period (30 year, 10 year and
5 year), and by race/ethnicity and gender.

A

B

Figure 2 - Geographic distribution of current incidence and mortality rates for oral
cancer in the US: Age-adjusted incidence (A) and mortality (B) rates for all US states,
for all races, all ages and both sexes, were ranked in quantiles, based upon cases per
100,000 and mapped: created by statecancerprofiles.cancer.gov.
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Nevada
North Carolina
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Ohio
Maine
Idaho
North Dakota
Wyoming
United States

APC
+4.6%
+4.0
+3.5
+3.4
+2.2
+1.0
+0.5
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-1.1%

Mortality
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2.6/100,000

Incidence
11.2/100,000
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Figure 3 - Annual percent change (APC) in mortality rates for oral cancer, 1999-2003:
Annual Percent Change (APC) for the age-adjusted mortality rates for cancer of the
oral cavity and pharynx, for all ages, genders and races, sorted by US state, 19992003, were created by statecancerprofiles.cancer.gov, using NCI SEER*Stat and
sorted. Eight states were identified with positive, increasing APC using this method.
*N/Q: Data not provided because it did not meet United States Cancer Statistics
(USCS) data quality standards for one or more years during the rate period of data
collection.

A

B

Figure 4 - Historical trends for oral cancer mortality in Nevada: Historical trends
(1980-2004) of mortality from oral cancer were sorted by race/ethnicity and gender
(A) using NCI SEER*Stat and regression lines calculated using the Joinpoint
Regression Program. Increasing trend in mortality among white males (1997-2004)
was further delineated by age (B).
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Figure 5 - Historical trends for oral cancer mortality in Idaho: Historical trends (19802004) of mortality from oral cancer were sorted by race/ethnicity and gender (A)
using NCI SEER*Stat and regression lines calculated using the Joinpoint Regression
Program. Mortality among white males was sorted further by age (B).

A

B

Figure 6 - Historical trends for oral cancer mortality in North Dakota: Historical
trends (1980-2004) of mortality from oral cancer were sorted by race/ethnicity and
gender (A) using NCI SEER*Stat and regression lines calculated using the Joinpoint
Regression Program. Mortality among white males was then stratified by age (B).
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Figure 7 - Historical trends for oral cancer mortality in North Carolina: Historical
trends (1980-2004) of mortality from oral cancer were sorted by race/ethnicity and
gender (A) using NCI SEER*Stat and regression lines calculated using the Joinpoint
Regression Program. The increasing trend among black males was sorted further by
age (B).
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Tables
Table 1 - Comparison of annual percent change (APC) in oral cancer mortality among
US states with higher than average incidence and mortality: US states from the
highest two quantiles of current oral cancer incidence and mortality were sorted in
descending order to compare with recent (1999-2003) APC rate trends in mortality.
Among these, three states were found to have increasing APC, Maine, Nevada, and
Wyoming.
US states
APC trend
Mortality rate
Incidence rate
(elevated incidence)
(recent)
(current)
(current)
District of Columbia
-4.6%
4.4/100,000
13.7/100,000
Oklahoma
-1.5
2.5
12.7
Louisiana
-1.2
3.4
12.7
Georgia
-2.8
2.9
12.6
Florida
-3.1
2.9
12.5
Maine
+2.2
3.3
12.2
New Hampshire
-0.9
3.2
11.8
Maryland
-2.9
2.5
11.6
Alabama
-1.2
3.3
11.5
Wisconsin
-1.5
2.6
11.5
Kentucky
-1.5
2.9
11.4
Nevada
+4.6
3.3
11.2
Massachusetts
-1.0
2.8
11.0
United States
-1.1%
2.6/100,000
10.4/100,000
US states
(elevated mortality)
District of Columbia

APC trend
(recent)
-4.6%

Mortality rate
(current)
4.4/100,000

Incidence rate
(current)
13.7/100,000

Arkansas
South Carolina
Louisiana
Alabama
Maine
Nevada
New Hampshire
Wyoming
Mississippi
Tennessee
United States

0.0
-3.7
-1.2
-1.2
+2.2
+4.6
-0.9
+0.1
-0.1
-1.1
-1.1%

3.5
3.5
3.4
3.3
3.3
3.3
3.2
3.2
3.0
3.0
2.6/100,000

10.6
10.1
12.7
11.5
12.2
11.2
11.8
N/Q*
N/Q*
N/Q*
10.4/100,000

*N/Q Data not provided because it did not meet United States Cancer Statistics
(USCS) data quality standards for one or more years during the rate period of data
collection.
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CHAPTER 2
ANALYSIS OF PRIMARY RISK FACTORS FOR ORAL CANCER FROM
SELECT US STATES WITH INCREASING RATES
This chapter has been accepted for publication in the peer-reviewed scientific journal
Tobacco Induced Diseases and is presented in the style of that journal. The complete
citation is:
Bunnell, A, Pettit N, Reddout N, Sharma K, O’Malley S, Chino M, Kingsley K.
Analysis of primary risk factors for oral cancer from select US states with increasing
rates. Tobacco Induced Diseases 2010 In Press.
Abstract
Objectives: To examine the primary risk factor for oral cancer in the US,
smoking and tobacco use, among the specific US states that experienced short-term
increases in oral cancer incidence and mortality.
Methods: Population-based data on oral cancer morbidity and mortality in the
US were obtained from the National Cancer Institute’s (NCI) Surveillance,
Epidemiology, and End Results (SEER) database for analysis of recent trends. Data
were also obtained from the Centers for Disease Control and Prevention (CDC)
Behavioral Risk Factor Surveillance System (BRFSS) to measure current and former
trends of tobacco usage. To comprehensive measures of previous state tobacco use
and tobacco-related policies, the Initial Outcomes Index (IOI, 1992-1993) and the
Strength of Tobacco Control index (SoTC, 1999-2000) were also used for evaluation
and comparison.
Results: Analysis of the NCI-SEER data confirmed a previous report of
geographic increases in oral cancer and demonstrated these were state-specific, were
not regional, and were unrelated to previously observed increases among females and
minorities. Analysis of the CDC-BRFSS data revealed these states had relatively
higher percentages of smokers currently, as well as historically. In addition, analysis
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of the IOI and SoTC indexes suggest that many factors, including cigarette pricing,
taxes and home or workplace bans, may have had significant influence on smoking
prevalence in these areas. Trend analysis of these data uncovered a recent and
significant reversal in smoking rates that suggest oral cancer incidence and mortality
may also begin to decline in the near future.
Conclusion: Due to the rising costs of health care in the US and the limited
resources available for health prevention efforts, it is essential to organize and direct
more effective efforts by public health officials and epidemiologists, as well as
funding from local, state and federal governments, to reduce and eliminate identified
health disparities. This study provides evidence how these efforts may be directed to
specific geographic areas, and towards the white males, previously thought to be
unaffected by the increases in oral cancer among females and minorities.
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Background
Although oral cancer incidence and mortality rates have increased worldwide,
these rates have been slowly and steadily declining among the US population over the
past thirty years [1,2]. Despite the overall declining trends of oral cancer in the US,
these declines are neither consistent nor uniform within this population [3,4].
Researchers have found that the incidence among specific demographic subgroups
may have actually increased over this same time period [5-7]. Recent studies have
shown that rates of oral cancer have been steadily declining among males, but have
risen sharply among females [8]. More specifically, the declining rates observed
among males were specific mainly to white males, while increasing incidence was
found among minorities, and black males, in particular [8]. A new study of oral
cancer epidemiology has found that increases in incidence and mortality may also
exhibit geographic specificity within the US [9], providing compelling rationale to
analyze the risk factors for oral cancer within these specific geographic areas and
among these specific demographic subgroups.
Oral cancer incidence and mortality are correlated strongly with two major
risk factors, tobacco use – consisting primarily of smoking in the US, and to a lesser
extent, heavy alcohol use, which together account for the overwhelming majority of

25

cases [10].

A recent study of smoking and tobacco use in the US found that rates

declined sharply among males between 1965 and 1990, while the rates among females
and minorities had less pronounced declines, and in some instances, may have
increased [11]. In fact, more recent studies provide strong evidence that increasing
usage of non-traditional forms of tobacco in the US, such as cigars and water pipe
smoking, have become increasingly popular among females and minorities [12].
Although many studies have found correlations and linkages between increased
workplace participation and social mobility, as well as acceptance and availability of
tobacco products with the increasing rates of oral cancer among females and
minorities, no studies to date have yet examined the relationship between increasing
rates of oral cancer in a small subset of US states and the primary risk factors for oral
cancer.
A review of oral cancer epidemiology in Europe revealed morbidity and
mortality have been steadily decreasing since the early 1980s, similar to the trends
observed in the US [13].

Temporal and geographic patterns, however, have

demonstrated increasing oral cancer rates among specific eastern European countries
following the disintegration and dissolution of the Soviet Union [14,15]. These
studies have demonstrated the increases were highly correlated to changes in exposure
to the primary risk factors for oral cancer, including tobacco and alcohol, which
became more readily available during this time [14,15]. Although no analogous
geopolitical events have precipitated rapid, sharp increases in the availability of either
tobacco or alcohol within these select US states with increasing oral cancer rates,
significant differences in cigarette pricing and taxes, as well as specific laws
regarding smoking bans, may have created state-specific environments that influence
the prevalence of these oral cancer risk factors over time.

26

This study sought to examine the primary risk factors for oral cancer, focusing
specifically on tobacco use and smoking prevalence, among the US states recently
found to have increasing short-term oral cancer incidence and mortality rates,
including Nevada, North Carolina, Iowa, Ohio, Maine, Idaho, North Dakota and
Wyoming [9]. More specifically, the working hypothesis for this study was that statespecific environmental factors may have led to increased tobacco use within these
states. Data from the National Cancer Institute (NCI) Surveillance, Epidemiology and
End Results (SEER) database, and the Behavioral Risk Factor Surveillance System
(BRFSS), supported by the Centers for Disease Control and Prevention (CDC), were
used to access and generate oral cancer statistics and comparisons of risk factor
prevalence in these specific US states, over time. The identification of states, regions,
or geographic areas with increased risk for oral cancer, as well as increased morbidity
and mortality, is important because these represent sites where public health education
and prevention efforts could be more effectively focused to improve health outcomes
and reduce health disparities.
Methods
Mortality data: Surveillance, Epidemiology, and End Results (SEER):
Population-based data on oral cancer in the US were obtained from the Surveillance,
Epidemiology, and End Results (SEER) program. SEER provides cancer incidence
and survival data from population-based cancer registries, representing approximately
25% of the US population [16]. All oral cancer statistics in this report are based on
SEER incidence and National Center for Health Statistics (NCHS) mortality statistics,
which consisted of cancers of the oral cavity, pharynx and lip [17]. Oral cancer
mortality rates between 1975 and 2005 were also obtained from SEER for each year,
age-adjusted to the year 2000 standard US population. Deaths qualified for inclusion
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in SEER oral cavity and pharyngeal cancer if the underlying cause of death was
specific for head and neck cancers [18]. The overall mortality trends over time were
calculated and graphed based on available data from 1981-2005.
Annual percent change (APC) for selected US states: Recent trend data in
death rates from oral cancer in individual US states were calculated by the National
Cancer Institute (NCI) SEER*Stat using data provided by the National Vital Statistics
System public use data file (SEER) and from the State Cancer Registries using the
Joinpoint Regression program and are expressed as the annual percent change (APC)
over the reported trend period (1999-2003, for example) for selected US states. These
states included Nevada (NV), North Carolina (NC), Iowa (IA), Ohio (OH), Maine
(ME), Idaho (ID), North Dakota (ND), Wyoming (WY), Arizona (AZ), California
(CA), Oregon (OR) and Utah (UT). Trends calculated using the Joinpoint Regression
statistical software program model the natural logarithm of the rates, identifying years
at which any given trend changes, connecting these years graphically by a series of
straight line segments [19,20].

Current annual death rates of oral cancers from

individual US states were similarly obtained and the most recent data available (2003,
2004 or 2005) at the time of article preparation were reported.
Risk factor data: Behavioral Risk Factor Surveillance System (BRFSS):
Historical risk behavior data for tobacco use from selected US states were obtained
from the Behavioral Risk Factor Surveillance System (BRFSS). BRFSS is among the
largest health surveillance and survey systems, responsible for tracking data monthly
and reporting health conditions and risk behaviors from all US states, the District of
Columbia, Puerto Rico, the U.S. Virgin Islands, and Guam, since 1984 [21]. BRFSS
is part of the National Center for Chronic Disease Prevention and Health Promotion,
sponsored by the Centers for Disease Control and Prevention (CDC). Data included
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four level smoking status (Smoke Every Day; Smoke Some Days; Former Smoker;
Never Smoked), and adults who are current smokers. Temporal data files were
available for all states after 2001, and from selected states dating from 1984.
Initial Outcomes Index (IOI) and Strength of Tobacco Control (SoTC): Statespecific data and rankings that form the US State Tobacco Control Initial Outcomes
Index (IOI) were obtained from a previous report [22]. Measures used to generate the
IOI index included smoking prevalence, computed as the percentage of current
smokers who indicated at the time of the survey they smoked either every day or
some days, per capita cigarette consumption, computed using total number of packs
removed and sold in any given month divided by the US Bureau of Census estimates
for state population aged 18 years or older at the time of the survey, weighted
averages for cigarette prices during the time period analyzed, and the prevalence of
workplace and home smoking bans. For the index factors (cigarette price per pack,
workplace smoking bans among ever smokers and home smoking bans among ever
smokers) z scores were calculated and summed to form a tobacco control IOI, which
was correlated with adult smoking prevalence and the point estimate of per capita
cigarette consumption.

Similarly, state-specific data and rankings from 1999-2000

form the standardized Strength of Tobacco Control (SoTC) index, which were also
obtained from previous reports [23, 24]. Positive IOI or SoTC index scores indicate
relatively robust state tobacco controls, including smoking bans, and generally reflect
higher cigarette prices and taxes, while negative index scores indicate states with
weaker tobacco controls, fewer smoking bans and comparatively lower cigarette
prices and taxes.
Results
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Surveillance Epidemiology and End Results (SEER): Oral cancer rates in those
selected states with previously identified increasing APC [9] were recalculated and
updated to reveal any changes to the previous trends observed (Figure 1). This reanalysis confirmed the previous report that oral cancer rates have been decreasing in
most US states, however a small subset of states have experienced recent increases in
rates of death from oral cancer (Fig. 1B). This data revision also confirmed the
previous report that mortality in the state with the highest APC in oral cancer deaths,
Nevada, was decreasing for many years (1981-1995) (Fig. 1A). However, the distinct
reversal and subsequent upward trend in deaths from oral cancer in Nevada was found
to have begun earlier (1995-2005) than previously noted (1998-2004), providing
further confirmation this upward trend appears not only to be continuing (2004-2005),
but may also be increasing. In addition, this analysis confirmed these observed
increases were not among females or minorities, but instead were restricted primarily
to white males.
To determine if these trends were restricted to these particular states or if they
are part of a larger regional increase, oral cancer rates for US states with contiguous
geographic borders to Nevada were analyzed to determine any demonstrable changes
(Fig 1B). This analysis revealed the majority of states sharing a contiguous border
with Nevada, including Arizona, California, Oregon and Utah, have all experienced
decreasing rates of oral cancer deaths, similar to the national US trend. The only state
bordering Nevada found to have a positive oral cancer APC was Idaho, a state
previously identified as one of the subset of US states with increasing rates of death
from oral cancer [9].
Behavioral Risk Factor Surveillance System (BRFSS): Epidemiologic
evidence has previously demonstrated oral cancer incidence and mortality rates are
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correlated strongly with two major risk factors, tobacco use – consisting primarily of
smoking, and to a lesser extent, heavy alcohol use [10]. To assess the potential
relationship between tobacco use, the primary risk factor for oral cancer, and the
subset of US states with increasing oral cancer rates, data regarding tobacco use and
smoking prevalence in these states was obtained from the Behavioral Risk Factor
Surveillance System (BRFSS). Analysis of these data demonstrated that the majority
(7/8) of those states with elevated oral cancer APC also had current smoking rates
(2007, most current available data) at or above the national average (Table 1).
Moreover, all of the states sharing a contiguous border with Nevada, mainly with
decreasing rates of oral cancer, were found to have current smoking rates at or below
the national average.
Initial Outcomes Index (IOI): Although current smoking rates may indicate
state-specific usage for tobacco based on price, availability or other social and
economic factors, current oral cancer mortality rates are generally the result of
previous smoking prevalence [10]. Recent public health efforts have focused on
developing comprehensive, state-specific measures of previous tobacco use through
development of a comprehensive index that measured and ranked all US states
according to multiple factors, including per capita tobacco consumption, cigarette
prices, as well as workplace and home smoking bans. One such comprehensive index
or measure of previous smoking prevalence and tobacco control, known as the initial
outcomes index (IOI), ranked all US states for these various factors between 1992 and
1993. Analysis of the IOI index data revealed the majority of states with increasing
oral cancer APC also earned IOI scores in the LOW or MODERATE categories (6/8),
mainly the result of higher rates of smoking and lower rates of tobacco control, such
as lower cigarette prices and fewer smoking bans (Table 1). Conversely, all of the
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states sharing a contiguous border with Nevada, mainly those with decreasing oral
cancer rates, earned IOI scores of HIGH – suggesting these states had lower smoking
rates and higher overall tobacco controls, including higher cigarette prices and more
extensive smoking bans.
Strength of Tobacco Control (SoTC): Another comprehensive measure of
previous state tobacco usage, known as the strength of tobacco control (SoTC), was
subsequently developed by public health officials to rank and compare all US states in
1999 and 2000, similar to the IOI. Once again, an analysis of the SoTC index data
revealed the majority of states with increasing oral cancer APC earned negative SoTC
scores, with Nevada scoring the lowest (-1.42), suggesting that tobacco control in
these states remained comparatively weak and less than the national mean index
(mean=0.0, STD=1.20) (Table 1). In contrast, all of the states sharing a contiguous
border with Nevada had positive SoTC index scores. When combined in this manner,
these data provide compelling evidence that the current smoking prevalence in states
with elevated oral cancer rates may have long-standing, historical trends of tobacco
use and control that may explain, in part, these anomalous state-specific increases in
oral cancer.
Although the rates of oral cancer incidence and mortality have declined over
the past thirty years, a reversal of these trends has recently emerged during the shortterm, which may signify an important change in the epidemiology of this cancer. The
IOI, SoTC, as well as current smoking rates provide important information regarding
the overall prevalence of tobacco use at specific time points, indicating potential
geographic areas that may suffer from tobacco-induced diseases, including oral
cancer. A more detailed examination of the changes in short-term trends of tobacco
usage rates or smoking prevalence within these states was necessary to explore these
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potential interactions and effects. Based upon this information, data from BRFSS
regarding annual smoking prevalence for states with elevated oral cancer APC and
states with a contiguous border to Nevada were assessed to reveal any significant
changes (Figure 2).
Detailed analysis of this data revealed that most states with elevated oral
cancer APC were found to have increases in the prevalence of smoking during the
initial, short-term time period examined (1995 – 2000) (Fig. 2A). In addition, most
states sharing a contiguous border with Nevada were found to have decreases in the
prevalence of smoking over this same time period, with the notable exception of
Idaho. To evaluate how these short-term changes in smoking rates may have changed
over time, BRFSS smoking prevalence data for all available years (1995-2007) from
the individual state with the highest oral cancer APC, Nevada, were obtained and
plotted to reveal any significant trends (Fig. 2B). This analysis demonstrated that
although smoking rates in Nevada were initially increasing between 1995 and 1999,
these rates have begun a more recent year-by-year decline – although they remain
above the national average.
To determine any changes in smoking prevalence occurring in the states
examined so far, BRFSS data for all available years (1995-2007) were obtained and
short-term changes in smoking rates were evaluated to uncover any significant trends
(Table 2). This analysis revealed that all of the states identified with elevated oral
cancer APC also experienced an increase in smoking trends during one or more of the
first four time intervals examined (1995-2000, 1996-2001, 1997-2002, 1998-2003).
Furthermore, all of the states sharing a contiguous border with Nevada experienced
only decreasing rates of smoking during these same intervals, with the exception of
Idaho (Table 2). Moreover, these data revealed an important shift and reversal in
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smoking trends among the states with elevated oral cancer APC during the 1999-2004
interval. This reversal signified a dramatic decrease for each of these states, which
has continued during all subsequent intervals (2000-2005, 2001-2006, 2002-2007),
albeit by differing percentages.
To further examine the changes in smoking prevalence over time from those
states with elevated oral cancer APC, BRFSS data for each year were collected and
graphed (Figure 3). The year-by-year plot of individual states with elevated oral
cancer rates demonstrated that although some initial increases were observed in each
state, most states developed a general, decreasing trend that became evident between
1999 and 2001 (Fig. 3A). Plotting the smoking prevalence trends from Table 2 to
visualize the changes over five-year intervals revealed the dramatic shift from mainly
positive trends, or increases in reported state-wide smoking during the first four time
intervals to negative trends, or net decreases in smoking during all subsequent time
intervals (Fig. 3B).
A similar examination of changes in smoking rates over time was performed
using BRFSS data from those states sharing a contiguous border with Nevada to
reveal any significant changes in trends and for comparison with those states
experiencing elevated oral cancer APC (Figure 4). In detail, the year-by-year plot of
smoking trends from these states revealed that most experienced year-by-year
decreases for the vast majority of years examined, with the notable exception of
Nevada itself (Fig. 4A). A plot of the changes in smoking trends for each time period
from Table 2 revealed that all of these states experienced declining rates of smoking
during all intervals examined (1995-2000, 1996-2001, 1997-2002, 1998-2003, 19992004, 2000-2005, 2001-2006, 2002-2007), with the notable exceptions of Nevada and
Idaho (Fig. 4B).
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Discussion
The overall rates of cancer incidence and mortality have declined within the
US in recent decades, but are not uniform or consistent within this population [1-4].
Although strong evidence has shown increased rates among minority groups and
women during this same period [5-7], recent evidence has suggested rates are also
increasing within particular US states, creating additional health disparities [13].
This study re-examined those data and confirmed that oral cancer rates have increased
within this small subset of US states. Moreover, further analysis verified that these
trends are not part of larger, regional increases in oral cancer nor are they linked with
the previously observed increases among females and minorities, but instead represent
state-specific phenomenon with geographic specificity.
Oral cancer has been linked primarily to tobacco use and smoking [10],
therefore, this study sought to analyze comprehensive state demographic and
behavioral data necessary to reveal the current and historical trends of tobacco use
and smoking in these specific states. Although it was expected, and confirmed, that
states with higher rates of oral cancer had comparatively higher rates of current, as
well as former, smokers than other states, this study exposed more recent, short-term
trends that suggest these smoking rates have more recently reversed and are now
steadily decreasing over time.

Because oral cancer incidence and mortality are

generally the result of previous smoking prevalence, this reversal may signify that
oral cancer rates within this subset of US states will also begin to decline, although
previous observations suggest a lag time of many years [6,7,10,11].
Although epidemiologic studies of demographic and behavioral characteristics
provide invaluable methods for identifying subgroups with increased risk for oral
cancer within larger populations, this study provides strong evidence of other
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potential variables, including state-specific indexes of policies and pricing structures
for tobacco, that may create “geographic pockets” of increased risk, even among the
general population. In addition, the inclusion of workplace and home smoking bans as
integral components of the IOI and SoTC indexes may suggest these data have the
potential to provide more nuanced and comprehensive measures of state-specific
smoking activity and risk than the more commonly reported measures of current adult
smokers or per capita cigarette consumption. However, despite recent increases in the
number of workplace smoking bans passed in several of these states, the role of
second-hand smoke in the work or home environment may represent additional
factors that further complicate and exacerbate the effects of tobacco use within these
areas [25,26].
Aside from the confounding effects of second-hand smoke, several additional
limitations of this study should be noted. For example, some of these states have seen
dramatic shifts in population, including a rapid influx of both casino and construction
workers in Nevada, which were coupled with an influx of retired and elderly seeking
affordable housing in warmer climates [27]. Although the survey and sampling of
populations through the CDC, BRFSS and SEER should account for these shifts in
population demographics, the possibility remains that these shifts could have skewed
the data sampling, which may have resulted in the inaccurate representation of current
or former smokers in each state - thereby influencing the outcome of these analyses.

In addition, other potential risk factors for oral cancer have also recently been
identified and these underlying medical conditions may have some effects on the
different rates observed. For example, immune suppression and immune modulation
due to infection with the human immunodeficiency virus (HIV), or by pharmacologic
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means to prevent rejection of tissue , have increased in prevalence within the US
during these same time periods, although their recognized influences on the
development of oral cancers have been the subject of relatively fewer epidemiologic
investigations [28,29].

Additional evidence that other infectious agents, such as

human papillomavirus (HPV), may increase the risk of developing oral cancer and
contribute to its progression has also been accumulating [30-33]. Because few data
specific to oral HPV prevalence or infection rates are currently available [34],
assessing the potential association with increasing rates of oral cancer has remained
elusive.
Finally, additional studies examining other modulating factors for oral cancer
development have identified potential risk factors that may also influence overall
rates, incidence, and mortality.

Some studies have demonstrated an inverse

relationship between the consumption of fruits or vegetables and oral cancer risk,
indicating that dose-dependent reductions in oral cancer risk are possible with each
additional serving of fruits or vegetables consumed [35-38].

Moreover, recent

epidemiologic evidence has demonstrated that serum and tissue folate levels, highly
correlated with fruit and vegetable consumption, may be inhibited by tobacco or
alcohol use - known primarily for their direct and indirect carcinogenic effects rather
than their modulating effects on micronutrient absorption [39-41].

Although

preliminary epidemiologic studies have found inconclusive, and seemingly
contradictory, effects of folate status on oral cancer risk [42,43], no studies to date
have directly examined the association between folate status and state-specific or
demographic increases in oral cancers.
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Conclusion
Due to the rising costs of health care in the US and the limited resources
available for health prevention efforts, it is essential to organize and direct more
effective efforts by public health officials and epidemiologists, as well as funding
from local, state and federal governments, to reduce and eliminate identified health
disparities. This study provides evidence of state-specific increases in oral cancer that
are not associated with the increases previously observed among females and
minorities, thereby providing new insights regarding potential methods to identify
changes in relevant trends in geographic areas which may experience increases in
tobacco-induced diseases in the future. As state and local public health professionals
strive to formulate effective prevention and education programs for their residents,
understanding the relationships between cause and effect, as well as the primary or
secondary factors that more accurately indicate the potential for increased risk,
becomes more imperative.
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Figures
States with elevated oral cancer APC:
________________________________________
Nevada (NV)
+4.6%
North Carolina (NC)
+4.0%
Iowa (IA)
+3.5%
Ohio (OH)
+3.4%
Maine (ME)
+2.2%
Idaho (ID)
+1.0%
North Dakota (ND)
+0.5%
Wyoming (WY)
+0.1%
States with contiguous geographic border (NV):
________________________________________
Nevada (NV)
+4.6%
Idaho (ID)
+1.0%
Arizona (AZ)
-1.5%
California (CA)
-2.2%
Oregon (OR)
-0.8%
Utah (UT)
-0.9%
US average

A

-1.1%

B

Figure 1 – Analysis of state-specific oral cancer mortality data: Historical trends
(1981-2005) of mortality from oral cancer were sorted by race and ethnicity using
NCI SEER*Stat (National Cancer Institute Surveillance Epidemiology and End
Results) and regression lines calculated using the Joinpoint Regression Program. A)
Oral cancer deaths in Nevada were initially declining, but exhibited a distinct,
sustained upward trend among white males beginning in 1995. B) US states
previously identified with short-term increases in oral cancer rates were confirmed as
NV, NC, IA, OH, ME, ID, ND and WY, while states sharing a contiguous border with
Nevada generally experienced declining trends.
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Figure 2 – Analysis of smoking trends in specific US states: A) Analysis of the annual
percent change (APC) or change in smoking trends (1995-2000) from states with
elevated oral cancer rates demonstrated these states experienced positive, increasing
rates of smoking prevalence, while states sharing a contiguous border with Nevada
experienced simultaneous negative or declining rates of smoking, with the exception
of Idaho. B) Graphing the smoking prevalence in Nevada revealed a year-by-year
increasing trend which peaked in 1999 and subsequently began a steady, sustained
decline over successive years.
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Figure 3 – Analysis of annual smoking prevalence data in states with elevated oral
cancer APC: A) A plot of annual data regarding state smoking prevalence
demonstrates some initial variability among varying states, following by a more
general declining trend beginning between 1999 and 2001. B) Graphing the trend or
five-year annual percent change (APC) from these states revealed the more general
trend of variability during the initial time periods (1995-2000 through 1998-2003),
that was followed by more general declining trends in subsequent periods (1999-2004
through 2002-2007).
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Figure 4 – Analysis of annual smoking prevalence data in states sharing a contiguous
border with Nevada: A) A plot of annual data regarding state smoking prevalence
demonstrates a general declining trend for all states during the entire period of
available data, with the exception of Nevada, initially. B) Graphing the trend or fiveyear annual percent change (APC) from these states revealed the general declining
trends in all periods (1995-2000 through 2002-2007), with the notable exceptions of
Nevada and Idaho.

43

Tables
Table 1. Comparison of smoking rates and tobacco control in selected US states
_____________________________________________________________________
State
Current rate Comparison
IOI
SoTC
(2007)
(relative to US)
(1992-1993)
(1999-2000)
Elevated APC states:
NV
21.5%
ABOVE
+0.25
-1.42
NC
22.9
ABOVE
-4.46 (LOW)
-0.14
IA
19.8
SAME
-1.18 (LOW)
+0.41
OH
23.1
ABOVE
-2.81 (LOW)
-1.05
ME
20.2
ABOVE
+1.28 (HIGH)
-1.24
ID
19.1
BELOW
+1.33 (HIGH)
+0.13
ND
20.9
ABOVE
-0.29
-0.93
WY
22.1
ABOVE
-2.11 (LOW)
-0.92
Contiguous border states (NV):
NV
21.5%
ABOVE
AZ
19.8
SAME
CA
14.3
BELOW
ID
19.1
BELOW
OR
16.9
BELOW
UT
11.7
BELOW

+0.25
+2.99 (HIGH)
+4.62 (HIGH)
+1.33 (HIGH)
+2.70 (HIGH)
+4.01 (HIGH)

-1.42
+4.03
+3.73
+0.13
+0.90
-0.29

US average

N/A

mean=0.0
STD=1.20

19.8%

N/A

Table legend: NV (Nevada), NC (North Carolina), IA (Iowa), OH (Ohio), ME
(Maine), ID (Idaho), ND (North Dakota), WY (Wyoming), AZ (Arizona), CA
(California), OR (Oregon), UT (Utah).
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Table 2. Comparison of smoking trends in selected US states
_____________________________________________________________________
State
1995-2000
1997-2002
1999-2004
2001-200
1996-2001
1998-2003
2000-2005
2002-2007
Elevated APC states:
NV
+9.8 -4.6
-7.1 -16.8
-26.3 -20.3 -17.4 -17.3
NC
+0.7 0.0
+1.9 +0.8
-7.9 -13.4 -14.0 -12.9
IA
0.0 -6.3 +0.4
-7.2
-11.4 -12.1 -3.1 -14.6
OH
+0.3 -2.8 +5.9
-3.4
-6.1 -14.9 -18.8 -13.1
ME
-0.4 -5.5 +3.9 +5.8
-9.8 -12.6 -12.5 -14.5
ID
+12.6 -7.1 +3.5
-6.4
-19.1 -19.7 -14.2 -7.2
ND
+2.2 -5.5 -3.5
+2.5
-9.9 -13.4 -11.7 -2.7
WY
+8.1 -9.7 -1.2
+7.8
-9.2 -10.5 -2.7 -6.7
Contiguous border states (NV):
NV
+9.8 -4.6 -7.1 -16.8
AZ
-18.7 -9.2 -10.9 -4.5
CA
-10.9 -7.5 -10.8 -12.5
ID
+12.6 -7.1 +3.5 -6.4
OR
-5.4 -12.3 -8.2 -0.9
UT
-6.5 -4.3 -7.2 -16.1

-26.3
-7.9
-20.8
-19.1
-6.5
-25.0

-20.3
-8.6
-11.6
-19.7
-10.6
-10.8

-17.4
-15.3
-13.3
-14.2
-9.7
-25.7

-17.3
-15.3
-12.8
-7.2
-24.5
-8.5

Table legend: NV (Nevada), NC (North Carolina), IA (Iowa), OH (Ohio), ME
(Maine), ID (Idaho), ND (North Dakota), WY (Wyoming), AZ (Arizona), CA
(California), OR (Oregon), UT (Utah).
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CHAPTER 3
POTENTIAL EFFECTS OF DIETARY FOLATE SUPPLEMENTATION ON
ORAL CARCINOGENESIS, DEVELOPMENT AND PROGRESSION
This chapter has been accepted for publication in the peer-reviewed scientific journal
Journal of Dietary Supplements and is presented in the style of that journal. The
complete citation is:
Kingsley K.
Potential effects of dietary folate supplementation on oral
carcinogenesis, development and progression. Journal of Dietary Supplements
2010 In Press.
Abstract
Folates are associated with a variety of human health benefits, while folate deficiency
has been identified as a potential risk factor for many health problems and cancers,
due to its role in dysregulation of DNA synthesis, repair and methylation. The US
Food and Drug Administration adopted requirements for folate fortification in some
food products, which has resulted in an increase in mean dietary folate intake and a
concomitant reduction in the incidence of adverse health effects associated with folate
deficiency. This includes a significant reduction in the incidence of folate deficiencyassociated birth defects, such as spina bifida.
Although dietary folate supplementation protects normal, non-neoplastic cells
from turning cancerous by preventing folate deficiency, more recent evidence
suggests that folate supplementation may also contribute to some negative health
effects. For example, recent studies found that dietary folate supplementation resulted
in the increasing rate at which some slow-developing, early-stage colon cancers
proliferate. The role of folate supplementation, and its effects on already developing
colorectal cancers, now raises the question of whether folate might play a similar and
significant role in the growth and proliferation of other slow-developing, early-stage
cancers.
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Another group of slow-developing cancers, oral cancer, may take many years
or decades to develop and are often undetected and undiagnosed until later stages.
However, no studies to date have adequately examined the potential ability of folate
supplementation to alter the proliferative phenotype of established oral cancers,
although growing epidemiologic evidence now suggests this may be a distinct
possibility. The relatively long time horizon for development of oral cancers provides
an opportunity for folate supplementation to act as a potential modulator of oral tumor
growth and development.
In addition, many other factors are known to modulate cellular responses to
micronutrients and dietary supplements, such as folate. For example, high-risk human
papillomavirus (HPV) infection has been proven to modulate proliferative phenotypes
of many cancers to folate supplementation. Recent studies of HPV infection in a
significant fraction of oral cancers now confirm HPV alters growth and development
within this subset of oral cancers. These discoveries add further support that the
relationships between HPV infection, folate supplementation and oral cancer growth
should be thoroughly examined. These data are critical and necessary components for
understanding the impact of dietary folate supplementation and for directing more
targeted and focused clinical and translational research in the prevention and
treatment of oral cancers.
Discussion
Folic acid: Folates are associated with a variety of human health benefits, can
be found in a wide assortment of foods, and are highly concentrated in certain dietary
vegetables, grain products and some fruit juices [1].

Many important cellular

functions involve folate-dependent processes, including amino acid metabolism and
the formation of S-adenosylmethionine, the primary methyl donor for DNA
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methylation reactions [2]. Folate deficiencies, resulting from low consumption of
fruits and vegetables, strongly correlate with increased incidence of neural-tube
defects, many cancers, hyperhomocysteinemia and vascular disease [3-5].
Folate deficiency: Folate deficiency has been identified as a potential risk
factor for head and neck cancers, and oral cancers more specifically, due to its
primary role in dysregulation of DNA synthesis, repair and DNA methylation
associated with carcinogenesis [6]. The source of some folate deficiencies can be
traced to a common DNA polymorphism in the methylenetetrahydrofolate reductase
(MTHFR) gene, which encodes the enzyme responsible for producing the circulating
form of folate [7, 8]. Other research has demonstrated that insufficient dietary folate
intake, and poor diet in general, may be responsible for as much as 10-15% of all
cases of oral cancer [9, 10]. In addition, other significant behavioral risk factors for
oral cancer, such as tobacco and alcohol use, have been demonstrated to interfere with
folate absorption, as well as increasing the rate of folate excretion by the kidney,
thereby lowering folate concentrations in serum and tissues [11-13].
Folate supplementation: In an effort to reduce poor health outcomes
associated with dietary folate deficiency, and to reduce incidence of neural tube
defects, the US Food and Drug Administration (FDA) adopted requirements for folate
fortification of all enriched cereal grain products beginning in 1996 [14]. USDA
fortification guidelines specified each serving should contain at least 25% of the
USDA recommended daily intake (RDI) of 400 micrograms per day (100 micrograms
per serving). Nutrition scientists and epidemiologists, using data from the National
Health and Nutritional Examination Survey (NHANES), demonstrated folate
fortification and supplementation in the US has resulted in higher mean dietary folate
intake, increasing from 275 to 351 micrograms per day. This correlates with a
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significant rise in folate concentrations measured in serum, as well as erythrocytes
and tissues, increasing from 11.4 nmol/L to 26.9 nmol/L and 375 nmol/L to 590
nmol/L, respectively [15].

The Centers for Disease Control and Prevention (CDC)

attributes the 26% reduction in the incidence of neural tube defects in the US to these
measures [16].
Folate toxicology: Although numerous health benefits are derived from
mandatory folate supplementation, this policy can also create conditions of nutritional
excess (hyperfolatemia) in some individuals, eliciting adverse clinical effects. Folate
concentrations within the normal physiologic range provide health benefits, however
concentrations falling outside of this range, including deficiency (hypofolatemia) or
excess (hyperfolatemia), can elicit strong adverse effects - the classic hormetic doseresponse relationship [17]. Inadvertent, but excessive, folate intake and higher folate
serum levels above 400 micrograms per day are now known to clinically ‘mask’
megalobastic anemia, caused by vitamin B12 deficiency [18]. In addition, hyper
supplementation of folate above these levels, extending to more than five milligrams
per day, also causes neurologic damage in patients with undiagnosed pernicious
anemia [19]. Recent studies and epidemiologic reviews now suggest that mandatory
folic acid fortification may, in some cases, increase the risk of some cancers – due in
part to this hormetic dose-response relationship but which may not be restricted to
conditions involving hyper- and hypofolatemia [20, 21].
Folate and cancer: These seemingly contradictory findings may be explained
by the dual roles of folate; the dose of folate supplementation determines the hormetic
dose-response effects, while the timing of folate administration may influence a nonhormetic response within the normal physiologic range. While adequate folate status
seems to protect normal, non-neoplastic cells from turning cancerous, normal levels
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of folate also seem to increase the rate and speed at which cancerous cells grow.
Conversely, folate depletion impairs existing cancers from growing, but can also
simultaneously increase the risk of forming new cancers at other sites or tissues.
Although treatment of folate deficiency with supplementation is an effective strategy
to prevent oncogenesis, folate supplementation has an opposite effect on any existing
or early-stage cancers or neoplasms [21, 22]. Cancers, by definition, are composed of
rapidly dividing cells, thereby exhibiting an increased need for folate. Consequently
anti-folate therapy has been used successfully to inhibit the growth of many tumors
and metastatic cancers [23, 24].
Oral cancer and folate: Oral carcinogenesis is a process that typically
involves many separate, inter-related risks and corresponding mechanisms of
transformation [25, 26]. This process may take many years or decades to become
clinically apparent, thereby providing a window of opportunity for folate
supplementation to modulate tumor growth and development.

Epidemiologic

evidence has demonstrated the major risk factors for developing oral cancer are the
use of tobacco and alcohol, known for their direct and indirect carcinogenic effects
[27, 28]. However, these risk factors are also known for their ability to decrease
serum and tissue folate levels [11-13].

Although some preliminary work and

epidemiologic studies have found inconclusive, and seemingly contradictory, effects
of MTHFR mutation and folate status on oral cancer risk, no studies to date have
directly examined the effects of folate on existing or established oral cancers [8, 29].
Folate and p53 expression: Most recently it has been shown that the effect of
folate status differs significantly according to the p53 expression profile of the
particular tumor [30]. Folate intake confers a protective effect against tumors that
over-express p53, but has no effect on tumors that exhibit wild type p53 expression.
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Interestingly, many of the earliest detectable events in oral carcinogenesis include
disruptions to growth inhibitory or tumor suppression signals, most commonly
involving proteins regulating the G1/S transition of the cell cycle – including p53, as
well as Rb, bcl-2, and p16 [31-33].
This intracellular dysregulation is facilitated in part by tobacco carcinogens,
including polycyclic aromatic hydrocarbons (PAH) and nicotine-derived nitrosamines
(NDN), which mediate oral carcinogenesis by activating DNA methyltransferases.
These enzymes preferentially methylate CpG-rich DNA sequences found in exons
248 and 273 of the p53 tumor suppressor gene, causing the transcriptional
deregulation and subsequent mutation during DNA replication [34, 35].

p53

deregulation then reduces the expression of other growth inhibitory regulators, such as
p21 and bcl-2. These regulators function to prevent the inactivation of the tumor
suppressor Rb and to induce apoptosis [36, 37].

PAH and NDN also induce

deregulation of p16, an inhibitor of cyclin CDKs, and p14/p29. p14/p29 functions to
inactivate mdm-2, which in turn down-regulates the p53 tumor suppressor [38],
further complicating the potential effects and inter-relationships between folate
supplementation and oral cancer development. Based upon this information, the
relationship between p53 expression, folate and oral carcinogenesis becomes clearly
more complex than mere dysregulation of G1/S cell cycle mediators.
Oral cancer and HPV: Although there is consensus among epidemiologists
that most oral cancers originate from the deleterious effects of tobacco use and
alcohol, recent evidence has demonstrated that human papillomavirus (HPV) infection
is also a separate, independent risk factor for developing oral cancer [39, 40]. The
human papillomaviruses are a family of dozens of related viruses that are involved in
the development of warts and some cancers, more specifically cervical cancers [41].
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HPV oncoproteins disrupt the function of known tumor suppressor genes, leading to
the production of transcription factors that ultimately drive cell proliferation,
transformation and carcinogenesis [42-44].
Recent evidence indicates the HPV types that cause cervical cancer are also
found in a subset of oral cancers (30%) and are now thought to contribute to
carcinogenesis in the oral cavity by mechanisms similar to those involved with the
development of cervical cancers [39, 45, 46].

More specifically, the HPV

oncoproteins, E6 and E7, produce ‘mdm-2-like’ proteins which bind to p53 and
disrupt the tumor suppressor functions.

These oncoproteins also affect other

associated tumor suppressors, including Rb and bcl-2, ultimately driving cell
proliferation, transformation and carcinogenesis [47].
HPV, folate and carcinogenic progression: Although great scientific emphasis
has been placed upon HPV as the primary cause of cervical cancers and its
involvement in carcinogenic progression of other cancers [41], less attention has been
focused on the secondary factors that are associated with progression from subclinical
HPV infection to invasive carcinoma. Among the secondary factors that limit virus
production and carcinogenic progression is CpG methylation of the HPV genome [4850]. Several studies now confirm that CpG site-specific methylation of HPV DNA,
mediated in part by folate availability, is sufficient to suppress neoplastic progression
[51-54]. In contrast, demethylation or hypomethylation of HPV-DNA sequences is
required for transformation, revealing the importance of preferential DNA
methylation at CpG sites in the HPV long control region (LCR) between L1 and E6
HPV genes, in addition to the tumor suppressor sites in p53 exons 248 and 273 that
were already discussed [55]. Because HPV has the potential to initiate oncogenesis,
and also to modulate oral cancer growth and folate plays a central role in mediating
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the availability of methyl groups for CpG-specific DNA methylation (modulating
both p53 and HPV mRNA expression) – a thorough investigation of these interconnected and inter-related mechanisms in oral cancers must be undertaken.
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Figure 1. Overview of selected environmental influences and genetic pathways in oral
cancers that may be affected by folate supplementation.

Summary
The role of folate supplementation, and its effects on already developing
colorectal and breast cancers, now raises the question of whether folate might play a
similar and significant role in the growth and proliferation of already developing oral
cancers. To date, no studies have examined the potential ability of folate to alter the
proliferative phenotype of established oral cancers, although growing epidemiologic
evidence now suggests this may be a distinct possibility.

Moreover, the inter-

connected role of HPV infection, and its association with the growth and development
of a subset of oral cancers, has not been explored with relation to folate
supplementation or folate status. These data are critical and necessary components
needed in order to establish clinical and translational research in this area. The
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ultimate goal is to provide new clinical treatments and diagnostic criteria for the
approximately 45,000 new patients diagnosed with oral cancer in the US each year,
who face a 40% five-year survival rate that has not changed significantly in many
decades [56].
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CHAPTER 4
GENERAL DISCUSSION
In this study, I sought to determine the temporal and geographic patterns of
oral cancer morbidity and mortality within the US population. Using well-established
methods for epidemiologic research, I found a geographic and temporal pattern of
increased oral cancer rates in a select subset of US states, including Nevada. These
published results demonstrate that oral cancer rates within specific geographic
locations of the US have been, and are currently, increasing. These results clearly
demonstrated an important public health problem that exists within this state
population.
Based upon these results, I hypothesized that these observed increases were
associated with state-specific exposures of this population to the primary risk factor
for oral cancer development, tobacco use. I attempted to analyze the use of tobacco
within Nevada, as well as the neighboring states and found that rates of smoking and
tobacco use were higher in this state than in neighboring states, as well as in
comparison to national averages. However, further research showed that these rates
were also intricately linked to other factors that influence cigarette and tobacco
consumption. These included cigarette pricing and taxes, which were found to be
significantly lower than in other regional states, such as Arizona, California and Utah.
Moreover, the rates of smoking and tobacco use in Nevada, although historically
higher than neighboring states have recently begun to decline. This finding suggests
that oral cancer rates may soon begin to decline within this population in the next ten
to fifteen years, although significant input from public health officials will be required
to avoid further health disparities.
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The analysis of oral cancer primary risk factors provided the opportunity to
consider additional, secondary factors that may also be environmental mediators of
oral cancer risk. Based upon research from the evidence base I found that specific
nutritional and dietary changes within the US correlate strongly with the onset of the
oral cancer increases observed in Nevada. Specifically, the introduction of folate
supplementation into the US food supply was strongly associated with the increased
incidence and mortality from oral cancers in Nevada. Furthermore, other studies have
found that folate supplementation has increased the incidence and mortality from
other slow growing cancers, such as colorectal cancer. These discoveries are so
recent that virtually no research has explored the possibility that folate
supplementation may have influenced oral cancer rates in conjunction with other
factors, such as higher rates of smoking due to state-specific taxing and policies.
Recommendations
Foster Interdisciplinary Research: Because cancer remains a leading cause of
morbidity and mortality within the US and contributes substantially to the burden of
rising healthcare costs, it is critical that biomedical research scientists become familiar
with methods of public health investigation and epidemiologic research. Moreover, it
is important for public health professionals to collaborate with, and integrate, their
efforts with biomedical research scientists.

This study incorporated the basic

biomedical research focus of my laboratory, oral cancer growth and development,
with the important elucidation of an increasing public health problem and health
disparity in Nevada.
Encourage Curricular Integration: It is my recommendation that public health
professionals and educators incorporate these findings into health programs, curricula,
and public service announcements in order to better serve the population of Nevada.
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The School of Dental Medicine has found great success with integrating research into
the basic science and biomedical curriculum for doctoral-level students and it is my
hope that these established collaborative efforts will result in long-term collaboration
and participation between the School of Community Health Sciences and the School
of Dental Medicine.
Mentoring: In addition, it is my recommendation that future students explore
other aspects of oral cancer risk and epidemiology and to use this work as a
foundation from which to explore other important aspects of public health efforts in
this area. For example, an on-going research focus of my laboratory research will be
to explore the relationship between folate administration and supplementation with
oral cancer growth and proliferation. These studies can easily be linked with MPH
research projects that examine these correlations within the patient population at the
School of Dental Medicine, providing an additional avenue for interdisciplinary
research and collaboration
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